Melanoma trials in Russia

4 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.

• Phase 4Taking people
  Dabrafenib and/or Trametinib Rollover Study

  Where

  Moscow

  Age

  18 years to 100 years

  People

  100 worldwide

  Run by

  Novartis Pharmaceuticals

  See details and how to joinNCT03340506 · EU 2023-509318-13-00
• Phase 1/2Taking people
  BI-1808 as a Single Agent and With Pembrolizumab (KEYTRUDA® ) in Treatment of Advanced Malignancies(Keynote-D20)

  Where

  Omsk, Saint Petersburg

  Age

  18 years and over

  People

  250 worldwide

  Run by

  BioInvent International AB

  See details and how to joinNCT04752826 · EU 2023-509847-29-00
• Phase 2Taking people
  Efficacy And Safety Of Anti-PD-1/PD-L1 Antibodies In Combination With Bevacizumab And Metronomic Cyclophosphamide In Patients With Non-Small Cell Lung Cancer And Cutaneous Melanoma Previously Treated With Immune Checkpoint Blockade

  Where

  Saint Petersburg

  Age

  18 years and over

  People

  90

  Run by

  EuroCityClinic LLC

  See details and how to joinNCT07130032
• No phaseTaking people
  Biobank and Register of Patients With Agresive Tumors for Translational and Analytical Research

  Where

  Saint Petersburg

  Age

  1 year and over

  People

  1,000

  Run by

  N.N. Petrov National Medical Research Center of Oncology

  See details and how to joinNCT05539677